Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Zydus Lifesciences Limited ( (IN:ZYDUSLIFE) ) has provided an announcement.
Zydus Lifesciences Limited announced the successful closure of a USFDA surveillance inspection at its API Unit 1 in Ankleshwar, Gujarat, which concluded with no observations. This positive outcome underscores the company’s commitment to maintaining high-quality standards in its manufacturing processes, potentially strengthening its position in the pharmaceutical industry and reassuring stakeholders of its compliance with international regulatory requirements.
More about Zydus Lifesciences Limited
Zydus Lifesciences Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its active pharmaceutical ingredients (APIs) and formulations, catering to various therapeutic segments.
YTD Price Performance: -9.36%
Average Trading Volume: 45,846
Current Market Cap: 894.5B INR
See more data about ZYDUSLIFE stock on TipRanks’ Stock Analysis page.